Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study

PLoS One. 2016 Dec 2;11(12):e0166857. doi: 10.1371/journal.pone.0166857. eCollection 2016.

Abstract

Purpose: Statins are widely used by older persons in primary and secondary prevention of cardiovascular disease. Although serious adverse events are rare, many statin users report mild muscle pain and/or muscle weakness. It's unclear what impact statins exert on a patient's daily life. Research on statin related side effects in older persons is relatively scarce. We therefore investigated the relation between statin use and self-reported hindering muscle complaints in older persons in the general population.

Methods: The present research was performed within the Integrated Systematic Care for Older Persons (ISCOPE) study in the Netherlands (Netherlands trial register, NTR1946). All registered adults aged ≥ 75 years from 59 participating practices (n = 12,066) were targeted. Information about the medical history and statin use at baseline and after 9 months was available for 4355 participants from the Electronic Patient Records of the general practitioners. In the screening questionnaire at baseline we asked participants: 'At the moment, which health complaints limit you the most in your day-to-day life?' Answers indicating muscle or musculoskeletal complaints were coded as such. No specific questions about muscle complaints were asked.

Results: The participants had a median age of 80.3 (IQR 77.6-84.4) years, 60.8% were female and 28.5% had a history of CVD. At baseline 29% used a statin. At follow-up, no difference was found in the prevalence of self-reported hindering muscle complaints in statin users compared to non-statin users (3.3% vs. 2.5%, OR 1.39, 95% CI 0.94-2.05; P = 0.98). Discontinuation of statin use during follow-up was independent of self-reported hindering muscle complaints.

Conclusion: Based on the present findings, prevalent statin use in this community-dwelling older population is not associated with self-reported hindering muscle complaints; however, the results might be different for incident users.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Activities of Daily Living*
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Diagnostic Self Evaluation*
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Male
  • Musculoskeletal Diseases / chemically induced
  • Musculoskeletal Diseases / epidemiology*
  • Self Report*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding

This study was funded by ZonMw, the Netherlands, Organization for Health Research and Development: ZonMw No. 311060201. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.